vs
Side-by-side financial comparison of Massimo Group (MAMO) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $21.0M, roughly 1.9× Massimo Group). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 9.5%, a 26.4% gap on every dollar of revenue. On growth, Massimo Group posted the faster year-over-year revenue change (15.7% vs -10.9%). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -16.5%).
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
MAMO vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.0M | $39.6M |
| Net Profit | $2.0M | $14.2M |
| Gross Margin | 41.5% | 73.1% |
| Operating Margin | 13.1% | 32.5% |
| Net Margin | 9.5% | 35.9% |
| Revenue YoY | 15.7% | -10.9% |
| Net Profit YoY | 215.0% | 117.2% |
| EPS (diluted) | $0.05 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.0M | $39.6M | ||
| Q3 25 | $17.0M | $43.4M | ||
| Q2 25 | $18.9M | $43.4M | ||
| Q1 25 | $14.9M | $47.3M | ||
| Q4 24 | $18.2M | $44.4M | ||
| Q3 24 | $25.6M | $53.1M | ||
| Q2 24 | $35.4M | $53.1M | ||
| Q1 24 | $30.2M | $54.8M |
| Q4 25 | $2.0M | $14.2M | ||
| Q3 25 | $1.5M | $12.8M | ||
| Q2 25 | $77.7K | $2.5M | ||
| Q1 25 | $-2.1M | $21.5M | ||
| Q4 24 | $-1.7M | $6.5M | ||
| Q3 24 | $-2.5M | $2.8M | ||
| Q2 24 | $2.8M | $18.5M | ||
| Q1 24 | $3.2M | $18.8M |
| Q4 25 | 41.5% | 73.1% | ||
| Q3 25 | 42.0% | 70.6% | ||
| Q2 25 | 36.3% | 69.2% | ||
| Q1 25 | 28.4% | 79.7% | ||
| Q4 24 | 19.6% | 76.3% | ||
| Q3 24 | 27.2% | 81.5% | ||
| Q2 24 | 32.5% | 74.2% | ||
| Q1 24 | 34.7% | 72.1% |
| Q4 25 | 13.1% | 32.5% | ||
| Q3 25 | 10.5% | 36.6% | ||
| Q2 25 | 0.8% | 33.6% | ||
| Q1 25 | -18.2% | 51.1% | ||
| Q4 24 | -15.4% | 10.6% | ||
| Q3 24 | 1.2% | 26.1% | ||
| Q2 24 | 10.1% | 51.4% | ||
| Q1 24 | 13.2% | 44.6% |
| Q4 25 | 9.5% | 35.9% | ||
| Q3 25 | 9.0% | 29.6% | ||
| Q2 25 | 0.4% | 5.7% | ||
| Q1 25 | -14.0% | 45.4% | ||
| Q4 24 | -9.5% | 14.7% | ||
| Q3 24 | -9.8% | 5.3% | ||
| Q2 24 | 8.0% | 34.8% | ||
| Q1 24 | 10.6% | 34.2% |
| Q4 25 | $0.05 | $0.15 | ||
| Q3 25 | $0.04 | $0.12 | ||
| Q2 25 | $0.00 | $0.02 | ||
| Q1 25 | $-0.05 | $0.21 | ||
| Q4 24 | $-0.05 | $0.05 | ||
| Q3 24 | $-0.06 | $0.03 | ||
| Q2 24 | $0.07 | $0.20 | ||
| Q1 24 | $0.08 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.8M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $23.7M | $248.3M |
| Total Assets | $51.4M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.8M | $164.1M | ||
| Q3 25 | $2.6M | $127.4M | ||
| Q2 25 | — | $152.7M | ||
| Q1 25 | $3.0M | $132.1M | ||
| Q4 24 | $10.2M | $125.0M | ||
| Q3 24 | — | $137.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $23.7M | $248.3M | ||
| Q3 25 | $21.7M | $248.0M | ||
| Q2 25 | $20.2M | $244.6M | ||
| Q1 25 | $19.9M | $226.4M | ||
| Q4 24 | $21.7M | $195.1M | ||
| Q3 24 | $22.5M | $205.0M | ||
| Q2 24 | $24.7M | $8.8M | ||
| Q1 24 | $18.1M | $9.0M |
| Q4 25 | $51.4M | $380.4M | ||
| Q3 25 | $44.4M | $321.4M | ||
| Q2 25 | $45.9M | $315.3M | ||
| Q1 25 | $46.4M | $284.6M | ||
| Q4 24 | $54.9M | $266.1M | ||
| Q3 24 | $57.1M | $296.5M | ||
| Q2 24 | $49.9M | $19.5M | ||
| Q1 24 | $47.3M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 2.01× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | $52.0M | ||
| Q3 25 | $633.2K | $-20.9M | ||
| Q2 25 | $-1.4M | $-8.3M | ||
| Q1 25 | $-3.3M | $1.9M | ||
| Q4 24 | $9.1M | $-7.3M | ||
| Q3 24 | $4.7M | $5.0M | ||
| Q2 24 | $-6.5M | $19.2M | ||
| Q1 24 | $-637.0K | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $9.0M | $-7.9M | ||
| Q3 24 | $4.6M | $4.6M | ||
| Q2 24 | $-6.7M | $18.3M | ||
| Q1 24 | $-741.4K | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | 49.7% | -17.8% | ||
| Q3 24 | 18.1% | 8.7% | ||
| Q2 24 | -19.0% | 34.5% | ||
| Q1 24 | -2.5% | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 0.2% | 1.3% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.7% | 1.6% | ||
| Q1 24 | 0.3% | 1.3% |
| Q4 25 | 2.01× | 3.66× | ||
| Q3 25 | 0.41× | -1.63× | ||
| Q2 25 | -17.92× | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | -2.30× | 1.04× | ||
| Q1 24 | -0.20× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAMO
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
